Robert Wong Biography and Net Worth

Robert has been our Chief Accounting Officer since May 2019.

Prior to joining Cytokinetics, Robert was at Genentech for over 23 years with roles of increasing responsibility in accounting, reporting, and internal controls, most recently as Interim Controller and Chief Accounting Officer. He has extensive experience in accounting for mergers, acquisitions and business development collaborations, reporting under US and International accounting standards, and complying with internal control regulations. Prior to Genentech, Robert was an Audit Manager at Ernst & Young LLP for over seven years.

Robert received his B.S. in Business Administration, Accounting & Finance from the University of California, Berkeley and is a certified public accountant.

A native San Franciscan, Robert enjoys his spare time working on a house or car repair project and spending time with his wife and three kids during their school and dance activities.

What is Robert Wong's net worth?: The estimated net worth of Robert Wong is at least $1.49 million as of February 21st, 2023. Mr. Wong owns 24,789 shares of Cytokinetics stock worth more than $1,485,357 as of May 16th. This net worth estimate does not reflect any other investments that Mr. Wong may own. Additionally, Mr. Wong receives an annual salary of $495,720.00 as CAO at Cytokinetics. Learn More about Robert Wong's net worth.
How old is Robert Wong?: Mr. Wong is currently 56 years old. There are 5 older executives and no younger executives at Cytokinetics. The oldest executive at Cytokinetics is Dr. James A. Spudich Ph.D., Co-Founder & Member of Scientific Advisory Board, who is 82 years old. Learn More on Robert Wong's age.
What is Robert Wong's salary?: As the CAO of Cytokinetics, Incorporated, Mr. Wong earns $495,720.00 per year. There are 3 executives that earn more than Mr. Wong. The highest earning executive at Cytokinetics is Mr. Robert I. Blum, CEO, President, Principal Financial Officer & Director, who commands a salary of $1,330,000.00 per year. Learn More on Robert Wong's salary.
How do I contact Robert Wong?: The corporate mailing address for Mr. Wong and other Cytokinetics executives is 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA, 94080. Cytokinetics can also be reached via phone at (650) 624-3000 and via email at [email protected]. Learn More on Robert Wong's contact information.
Has Robert Wong been buying or selling shares of Cytokinetics?: Robert Wong has not been actively trading shares of Cytokinetics during the last quarter. Most recently, Robert Wong sold 2,234 shares of the business's stock in a transaction on Tuesday, February 21st. The shares were sold at an average price of $45.21, for a transaction totalling $100,999.14. Following the completion of the sale, the chief accounting officer now directly owns 24,789 shares of the company's stock, valued at $1,120,710.69. Learn More on Robert Wong's trading history.
Who are Cytokinetics' active insiders?: Cytokinetics' insider roster includes Muna Bhanji (Director), Robert Blum (CEO), Santo Costa (Director), David Cragg (Insider), L. Gage (Director), John Henderson (Director), Ching Jaw (CFO), Edward Kaye (Director), Fady Malik (EVP), B. Parshall (Director), Mark Schlossberg (SVP), Sandford Smith (Director), Wendall Wierenga (Director), and Robert Wong (CAO). Learn More on Cytokinetics' active insiders.
Are insiders buying or selling shares of Cytokinetics?: During the last year, insiders at the biopharmaceutical company sold shares 32 times. They sold a total of 380,121 shares worth more than $21,153,114.78. The most recent insider tranaction occured on May, 7th when EVP Fady Ibraham Malik sold 15,547 shares worth more than $1,012,265.17. Insiders at Cytokinetics own 3.4% of the company. Learn More about insider trades at Cytokinetics.
Information on this page was last updated on 5/7/2024.

Robert Wong Insider Trading History at Cytokinetics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/21/2023	Sell	2,234	$45.21	$100,999.14	24,789
2/3/2023	Sell	3,004	$45.00	$135,180.00	27,533
11/14/2022	Sell	2,100	$40.68	$85,428.00	30,537

Robert Wong Buying and Selling Activity at Cytokinetics

Cytokinetics Company Overview

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; CK-586, a small molecule cardiac myosin inhibitor, that is in Phase I clinical trial; and aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy. Cytokinetics, Incorporated has a strategic alliance with Ji Xing Pharmaceuticals Limited. The company was incorporated in 1997 and is headquartered in South San Francisco, California.

Today's Range

Now: $59.92

$59.55

$61.04

50 Day Range

MA: $66.95

$57.89

$75.05

2 Week Range

Now: $59.92

$25.98

$110.25

Volume

888,756 shs

Average Volume

2,693,624 shs

Market Capitalization

$6.28 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.72

Healthcare Takes A Big Step Forward With The Help Of AI

From The Bull Report | Ad

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

Robert Wong Biography and Net Worth

What is Robert Wong's net worth?

How old is Robert Wong?

What is Robert Wong's salary?

How do I contact Robert Wong?

Has Robert Wong been buying or selling shares of Cytokinetics?

Who are Cytokinetics' active insiders?

Are insiders buying or selling shares of Cytokinetics?